Epidemiology of ACE Inhibitor Angioedema Utilizing a Large Electronic Health Record

Journal of Allergy and Clinical Immunology: In Practice

Volumn 5, Issue 3, 2017, Pages 744-749

  Banerji, Aleena ^a,b   Blumenthal, Kimberly G ^a,b   Lai, Kenneth H ^c   Zhou, Li ^b,c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PARTNERS HEALTHCARE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Angioedema; Angiotensin converting enzyme; Drug allergy; Drug hypersensitivity; Electronic health record; Epidemiology

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ALLERGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BRONCHOSPASM; COHORT ANALYSIS; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; DIZZINESS; ELECTRONIC MEDICAL RECORD; FACE EDEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHROTOXICITY; RASH; RISK FACTOR; URTICARIA; WHEEZING; AGE; DRUG HYPERSENSITIVITY; ELECTRONIC HEALTH RECORD; FOLLOW UP; IMMUNOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; RISK; UNITED STATES; UTILIZATION;

AGE FACTORS; ALLERGENS; ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; DRUG HYPERSENSITIVITY; ELECTRONIC HEALTH RECORDS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; UNITED STATES;

EID: 85016459089     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2017.02.018     Document Type: Article

References (32)

1. 1 Ma, J., Lee, K.V., Stafford, R.S., Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004. Hypertension 48 (2006), 846–852.
2. 2 Messerli, F.H., Nussberger, J., Vasopeptidase inhibition and angio-oedema. Lancet 356 (2000), 608–609.
3. 3 Kelly, M., Donnelly, J.P., McAnnally, J.R., Wang, H.E., National estimates of emergency department visits for angioedema and allergic reactions in the United States. Allergy Asthma Proc 34 (2013), 150–154.
4. 4 Banerji, A., Clark, S., Blanda, M., LoVecchio, F., Snyder, B., Camargo, C.A. Jr., Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 100 (2008), 327–332.
5. 5 Gabb, G.M., Ryan, P., Wing, L.M., Hutchinson, K.A., Epidemiological study of angioedema and ACE inhibitors. Aust NZ J Med 26 (1996), 777–782.
6. 6 Sarkar, P., Nicholson, G., Hall, G., Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications. Can J Anaesth 53 (2006), 994–1003.
7. 7 Banerji, A., Oren, E., Hesterberg, P., Hsu, Y., Camargo, C.A. Jr., Wong, J.T., Ten-year study of causes of moderate to severe angioedema seen by an inpatient allergy/immunology consult service. Allergy Asthma Proc 29 (2008), 88–92.
8. 8 Krizova, A., Gardner, T., Little, D.L., Arcieri-Piersanti, V., Pollanen, M.S., Fatal laryngeal angioedema: a case report and a workup of angioedema in a forensic setting. Forensic Sci Med Pathol 11 (2015), 558–563.
9. 9 Ulmer, J.L., Garvey, M.J., Fatal angioedema associated with lisinopril. Ann Pharmacother 26 (1992), 1245–1246.
10. 10 Quan, M., Case study. ACE inhibitor-induced angioedema. Clin Cornerstone 9:Suppl 3 (2009), S34–S35.
11. 11 Toh, S., Reichman, M.E., Houstoun, M., Ross Southworth, M., Ding, X., Hernandez, A.F., et al. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med 172 (2012), 1582–1589.
12. 12 Makani, H., Messerli, F.H., Romero, J., Wever-Pinzon, O., Korniyenko, A., Berrios, R.S., et al. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol 110 (2012), 383–391.
13. 13 Malde, B., Regalado, J., Greenberger, P.A., Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol 98 (2007), 57–63.
14. 14 Brown, N.J., Snowden, M., Griffin, M.R., Recurrent angiotensin-converting enzyme inhibitor-associated angioedema. JAMA 278 (1997), 232–233.
15. 15 Beltrami, L., Zanichelli, A., Zingale, L., Vacchini, R., Carugo, S., Cicardi, M., Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema. J Hypertens 29 (2011), 2273–2277.
16. 16 Slater, E.E., Merrill, D.D., Guess, H.A., Roylance, P.J., Cooper, W.D., Inman, W.H., et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 260 (1988), 967–970.
17. 17 Sabroe, R.A., Black, A.K., Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br J Dermatol 136 (1997), 153–158.
18. 18 Mahoney, E.J., Devaiah, A.K., Angioedema and angiotensin-converting enzyme inhibitors: are demographics a risk?. Otolaryngol Head Neck Surg 139 (2008), 105–108.
19. 19 Brown, N.J., Ray, W.A., Snowden, M., Griffin, M.R., Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 60 (1996), 8–13.
20. 20 Campo, P., Fernandez, T.D., Canto, G., Mayorga, C., Angioedema induced by angiotensin-converting enzyme inhibitors. Curr Opin Allergy Clin Immunol 13 (2013), 337–344.
21. 21 Stauber, T., Confino-Cohen, R., Goldberg, A., Life-threatening angioedema induced by angiotensin-converting enzyme inhibitors: characteristics and risk factors. Am J Rhinol Allergy 28 (2014), 54–58.
22. 22 Loftus, P.A., Tan, M., Patel, G., Lin, J., Helman, S., Badhey, A., et al. Risk factors associated with severe and recurrent angioedema: an epidemic linked to ACE-inhibitors. Laryngoscope 124 (2014), 2502–2507.
23. 23 Mahmoudpour, S.H., Leusink, M., van der Putten, L., Terreehorst, I., Asselbergs, F.W., de Boer, A., et al. Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis. Pharmacogenomics 14 (2013), 249–260.
24. 24 Kampitak, T., Recurrent severe angioedema associated with imidapril and diclofenac. Allergol Int 57 (2008), 441–443.
25. 25 Kaplan, A.P., Greaves, M.W., Angioedema. J Am Acad Dermatol 53 (2005), 373–388.
26. 26 Ogbureke, K.U., Cruz, C., Johnson, J.V., Helfrick, J.F., Perioperative angioedema in a patient on long-term angiotensin-converting enzyme (ACE)-inhibitor therapy. J Oral Maxillofac Surg 54 (1996), 917–920.
27. 27 Peacock, M.E., Brennan, W.A., Strong, S.L., Prior, R.F., O'Neal, R.B., Van Dyke, T.E., Angioedema as a complication in periodontal surgery: report of a case. J Periodontol 62 (1991), 643–645.
28. 28 Sadeghi, N., Panje, W.R., Life-threatening perioperative angioedema related to angiotensin-converting enzyme inhibitor therapy. J Otolaryngol 28 (1999), 354–356.
29. 29 Schiller, P.I., Messmer, S.L., Haefeli, W.E., Schlienger, R.G., Bircher, A.J., Angiotensin-converting enzyme inhibitor-induced angioedema: late onset, irregular course, and potential role of triggers. Allergy 52 (1997), 432–435.
30. 30 Seymour, R.A., Thomason, J.M., Nolan, A., Angiotensin converting enzyme (ACE) inhibitors and their implications for the dental surgeon. Br Dent J 183 (1997), 214–218.
31. 31 Dyer, P.D., Late-onset angioedema after interruption of angiotensin converting enzyme inhibitor therapy. J Allergy Clin Immunol 93 (1994), 947–948.
32. 32 Mahmoudpour, S.H., Asselbergs, F.W., Terreehorst, I., Souverein, P.C., de Boer, A., Maitland-van der Zee, A.H., Continuation of angiotensin converting enzyme inhibitor therapy, in spite of occurrence of angioedema. Int J Cardiol 201 (2015), 644–645.